Showing results (861-870 of 1,835) with videos related to

Sort By:
Pageof 184
Onkologie|October 1, 1989
[Tumor markers in breast cancer: on the diagnostic value of serum determinations in clinical freedom from tumor and manifest disease]P Günczler, E Ogris, S Maca, et al.
Onkologie|October 1, 1989
[Serum level of the tumor marker CA 125 before second-look laparatomy in primary epithelial ovarian cancer in relation to intraoperative findings]H Meden, W Rath, A Teichmann, et al.
Onkologie|August 1, 1989
[Does immunoscintigraphy improve early diagnosis of metastatic or recurrent cancer?]T Hölting, M Steinbächer, U Kretzschmar, et al.
Onkologie|August 1, 1989
[Non-invasive follow-up control of tumor therapy following chemotherapy using 31P-MR spectroscopy in whole body tomography]W Semmler, P Bachert-Baumann, F Gückel, et al.
Onkologie|August 1, 1989
[Immunologic identification of undetectable neuroblastoma cells by current cytohistological studies of bone marrow samples]E S Gussetis, U Ebener, S Wehner, et al.
Onkologie|October 1, 1989
[Prognostic factors in small cell bronchial cancer]C Manegold, H Bülzebruck, P Drings, et al.
Onkologie|June 1, 1989
[Immunomodulation by leukocytolysis. On the significance of lectin-polysaccharide complexes]H Heine
Onkologie|October 1, 1989
Dose escalation and split course of 4-epidoxorubicin in combination chemotherapy (FEM II) of advanced gastric carcinoma. A phase-II trail of the 'Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)'W Queisser, H Flechtner, M E Heim, et al.
Onkologie|December 21, 2013
RAS, BRAF, and TP53 gene mutations in Taiwanese colorectal cancer patientsYa-Sian Chang, Shun-Jen Chang, Kun-Tu Yeh, et al.
Onkologie|December 21, 2013
Patient-related delay in presentation for cutaneous squamous cell carcinoma. A cross-sectional clinical studyDespoina Kakagia, Gregory Trypsiannis, Michael Karanikas, et al.
Pageof 184